Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics Revenue

Allogene Therapeutics had revenue of $43.00K in the twelve months ending September 30, 2024, up 26.47% year-over-year. In the year 2023, Allogene Therapeutics had annual revenue of $95.00K, down -39.10%.

• Revenue (ttm): $43.00K
• Revenue Growth: +26.47%
• P/S Ratio: 10,581.13
• Revenue / Employee: $185
• Employees: 233
• Market Cap: 454.99M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	95.00K	-61.00K	-39.10%
Dec 31, 2022	156.00K	-113.93M	-99.86%
Dec 31, 2021	114.09M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.